Seagen
SGEN
#546
Rank
ยฃ32.39 B
Marketcap
ยฃ171.70
Share price
-0.07%
Change (1 day)
61.79%
Change (1 year)

Seagen (SGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : ยฃ0.81 Billion

According to Seagen 's latest financial reports the company's total liabilities are ยฃ0.81 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Seagen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ0.71 B48.44%
2021-12-31ยฃ0.48 B28.88%
2020-12-31ยฃ0.37 B49.69%
2019-12-31ยฃ0.25 B39.08%
2018-12-31ยฃ0.18 B21.88%
2017-12-31ยฃ0.14 B-10.46%
2016-12-31ยฃ0.16 B17.3%
2015-12-31ยฃ0.14 B-11.43%
2014-12-31ยฃ0.15 B3.62%
2013-12-31ยฃ0.15 B1.36%
2012-12-31ยฃ0.15 B14.29%
2011-12-31ยฃ0.13 B21.7%
2010-12-31ยฃ0.10 B-3.07%
2009-12-31ยฃ0.11 B51.76%
2008-12-31ยฃ74.16 M55.84%
2007-12-31ยฃ47.59 M885.29%
2006-12-31ยฃ4.83 M-42.8%
2005-12-31ยฃ8.44 M6.12%
2004-12-31ยฃ7.95 M99.88%
2003-12-31ยฃ3.98 M9.4%
2002-12-31ยฃ3.63 M123.82%
2001-12-31ยฃ1.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ImmunoGen
IMGN
ยฃ0.19 B-75.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ8.25 B 914.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ37.58 M-95.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ60.7 M-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 10,569.01%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ46.00 B 5,554.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
ยฃ102.46 B 12,493.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 7,123.30%๐Ÿ‡บ๐Ÿ‡ธ USA